LEO Pharma presents its fourth session of MED (Medical Rapid Dialogues), which focuses on the treatment of psoriasis in primary care and dermatology

MEDs are a series of five talks by different health professionals focused on explaining and conveying scientific topics of importance in dermatology and their impact on patients’ quality of life. This fourth session focuses on the management of psoriasis in primary care and dermatology, with the aim of sharing her vision on the comprehensive management of patients with psoriasis. On this occasion, Dr. Sahuquillo begins by reflecting on the importance of patient access to medical professionals and the need to improve patient care, from initial diagnosis to subsequent treatment.

On the other hand, Dr. Pallister comments on the main criteria for referring patients with psoriasis from the primary care field. Among these, the importance of BSA (body surface area) for determining the severity of psoriasis, the presence of comorbidities in patients or cases of psoriatic arthritis, stands out. In short, Dr. Sahuquillo recommends referral to a dermatologist for those patients whose primary care physician considers they cannot be treated with topical treatment alone.

Dr. Sahukilu reports how knowledge of patients with psoriasis and its co-morbidities in many cardiovascular conditions has increased significantly in the past five to ten years. This means following a series of values ​​such as LDL, which is very high in most patients with psoriasis, and which can lead to more serious complications such as fatty liver and even liver cancer. Cardiovascular management is essential, and the role and knowledge of primary care physicians in this area stands out.

Also of note is Dr. Pallister’s reflection on the psychological dimension of pathology, how it affects patients’ quality of life and how current treatments can modify the normal development of psoriasis.
Finally, clinicians thought about the long-term needs of psoriasis patients, introducing the concept of proactive topical management, which consists of treatment twice a week when psoriasis is latent, to prolong the outbreak-free period.

You can see the full link here:

Abordaje integral del paciente con Psoriasis: de la Dermatología a la Atención Primaria

This content was developed by UE Studio, a content marketing and branded creative content company from Unidad Editorial, for LEO Pharma.

Leave a Comment